Skip to main content
NeopharmCO.,LTD. logo

NeopharmCO.,LTD. — Investor Relations & Filings

Ticker · 092730 ISIN · KR7092730001 KO Manufacturing
Open in API
Filings indexed 205 across all filing types
Latest filing 2024-12-05 Major Shareholding Noti…
Country KR South Korea
Listing KO 092730

About NeopharmCO.,LTD.

https://neopharm.co.kr

Neopharm is a science-based company specializing in the development, manufacturing, and sale of dermatological skincare and cosmetic products. A pioneer in skin barrier research, the company focuses on restoring skin homeostasis. Its core innovation is the proprietary Multi-Lamellar Emulsion (MLE) technology, which mimics the natural lipid structure of the skin to repair and strengthen its protective functions. The company's primary product lines, including the flagship brand Atopalm, are specifically formulated for sensitive, dry, and compromised skin. These non-steroid solutions are grounded in dermatological science to address various skin concerns.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by a major shareholder (It's Hanbul) and related parties in the company Neopharm. This falls under the category of Major Shareholding Notification (MRQ).
2024-12-05 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed by It's Hanbul regarding their holdings in Neopharm. This is a standard regulatory filing in South Korea (DART system) used to disclose changes in share ownership by major shareholders or insiders. This falls under the category of 'Director's Dealing' (DIRS) as it reports share transactions and ownership changes by a major shareholder/insider.
2024-11-28 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed with the Financial Supervisory Service (FSS) in South Korea. It details the acquisition of shares by IT'S HANBUL Co., Ltd. in NeoPharm Co., Ltd., resulting in a change in their total shareholding percentage. This type of filing is a standard regulatory requirement for major shareholders crossing ownership thresholds, which falls under the 'Major Shareholding Notification' category.
2024-11-28 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a short regulatory announcement (811 characters) notifying the market of an upcoming Investor Relations (IR) meeting/presentation. It provides the date, time, location, and purpose of the meeting. According to the 'Menu vs Meal' rule, since this is an announcement of an event/presentation rather than the presentation deck itself, and it is a regulatory disclosure of an event, it falls under the category of a general regulatory filing or announcement.
2024-11-13 Korean
분기보고서 (2024.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for NeoPharm, covering the period from January 1, 2024, to September 30, 2024. It contains detailed corporate information, financial data, business descriptions, and management discussions, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2024
2024-11-13 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard regulatory filing in South Korea (DART system) used by corporate insiders to disclose changes in their shareholdings. This corresponds to the 'Director's Dealing' category, which covers insider trades and changes in ownership by company directors and executives.
2024-11-04 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.